ARWR
Arrowhead Pharmaceuticals Inc
$81.48
1.01 (1.25%) Today
0.03 (0.04%) After-hours
— up— down
Market Cap
$11.48B+415.9%
Revenue (TTM)
$615.21M+14.1%
Net Income (TTM)
$-302,243,302
$-302,243,302EPS (TTM)
-2.15
-2.15Shares Out
140.86M
140.86MOpen
$82.00
$82.00Previous Close
$80.50
$80.50Day Range
$78.87 – $84.06
$78.87 – $84.0652-Week Range
$14.30 – $84.55
$14.30 – $84.55Beta
1.27
1.27Volume
2.69M
2.69MAvg Volume
2.16M
2.16MAnalyst Rating
Buy
BuyExchange
NASDAQ NMS - GLOBAL MARKET
NASDAQ NMS - GLOBAL MARKETAbout ARWR
Arrowhead Pharmaceuticals, Inc. is a publicly traded biopharmaceutical company based in Pasadena, California. Arrowhead's products in development act through RNA interference (RNAi) mechanisms of action. The company focuses on treatments for hepatitis B, liver disease associated with alpha 1-antitrypsin deficiency and cardiovascular disease.
